Home > Cashflow Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Financing Activities ₹-797 Cr₹-532 Cr₹-35 Cr₹-1,091 Cr₹-246 Cr

What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES is ₹-797 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Financing Activities
Mar2023₹-797 Cr
Mar2022₹-532 Cr
Mar2021₹-35 Cr
Mar2020₹-1,091 Cr
Mar2019₹-246 Cr

How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2023 ₹-797 Cr
Negative
Mar2022 ₹-532 Cr
Negative
Mar2021 ₹-35 Cr
Negative
Mar2020 ₹-1,091 Cr
Negative
Mar2019 ₹-246 Cr -

Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹104,312.3 Cr -0.9% 5% 19.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,071.0 Cr 0.2% -6.1% 55.7% Stock Analytics
CIPLA ₹111,808.0 Cr -2.5% -5.1% 48.6% Stock Analytics
ZYDUS LIFESCIENCES ₹101,202.0 Cr 1.8% 2.2% 88.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,035.0 Cr -3.7% -1.4% 26% Stock Analytics
MANKIND PHARMA ₹87,328.3 Cr -6.6% -6.6% NA Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-0.9%

5%

19.2%

SENSEX

-1.4%

-0.6%

20.1%


You may also like the below Video Courses